Metoprolol in the treatment of cardiovascular disease: a critical reappraisal

Research output: Contribution to journalReview article


Background: Extensive clinical experience on metoprolol has been gained in different cardiovascular conditions. Review: This paper discusses the use of metoprolol, with a focus on the extended-release formulation, in clinical practice in the light of existing evidence and current recommendations. This is a narrative review based on existing evidence and clinical experience of the author. Evidence on the use of metoprolol in heart failure, ischemic artery disease, arterial hypertension, and atrial fibrillation is well-established. Conclusions: Metoprolol still appears to be a suitable pharmacological option in different cardiovascular conditions. Research on this molecule is still active and new, promising settings of use are being explored and may provide relevant results in the years to come.

Original languageEnglish
Pages (from-to)1635-1643
Number of pages9
JournalCurrent Medical Research and Opinion
Issue number9
Publication statusPublished - Sep 2 2018


  • Atrial fibrillation
  • congestive heart failure
  • essential hypertension
  • ischemic heart disease
  • metoprolol succinate

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Metoprolol in the treatment of cardiovascular disease: a critical reappraisal'. Together they form a unique fingerprint.

  • Cite this